PADCEV EJFV — ASTELLAS, approved 2026-07-10 (BLA761137).
6,114 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.